Endoscopic Submucosal Dissection for Early GI Neoplasia in the United Kingdom

Last updated: May 27, 2025
Sponsor: Portsmouth Hospitals NHS Trust
Overall Status: Active - Recruiting

Phase

N/A

Condition

Neoplasms

Treatment

Endoscopic Submucosal Dissection

Clinical Study ID

NCT03039309
PHT/2016/45
  • Ages > 18
  • All Genders

Study Summary

Multicentre cohort study on the use of endoscopic submucosal dissection for the treatment of early gastrointestinal neoplasia.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Male or Female, aged 18 years or above undergoing endoscopic submucosal dissection

  • Participant is able to give informed consent for participation in the study

Exclusion

Exclusion Criteria:

  • Patients under the age of 18

  • Patients unable to give informed consent

Study Design

Total Participants: 500
Treatment Group(s): 1
Primary Treatment: Endoscopic Submucosal Dissection
Phase:
Study Start date:
August 05, 2016
Estimated Completion Date:
August 04, 2028

Study Description

Data will be collected from participating centres on en bloc resection, curative resection, R0 resection and complications/adverse events over a 2 year follow up period.

Demographic details on the patients included in the study will be captured alongside details on the size and location of their early gastrointestinal dysplastic/neoplastic lesions.

Connect with a study center

  • Portsmputh Hospitals NHS Trust

    Portsmouth, PO6 3LY
    United Kingdom

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.